Sign Up to like & get
recommendations!
0
Published in 2020 at "Hematology/oncology and stem cell therapy"
DOI: 10.1016/j.hemonc.2020.07.002
Abstract: BACKGROUND Acute promyelocytic leukemia is a peculiar disease with few studies that have investigated the prognostic significance of PML/RARA transcript level at diagnosis. PATIENTS AND METHODS This retrospective study included all cases diagnosed with acute…
read more here.
Keywords:
pml rara;
promyelocytic leukemia;
acute promyelocytic;
diagnosis ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of Ginseng Research"
DOI: 10.1016/j.jgr.2020.05.001
Abstract: Background Acute promyelocytic leukemia (APL) is a hematopoietic malignancy driven by promyelocytic leukemia–retinoic acid receptor A (PML-RARA) fusion gene. The therapeutic drugs currently used to treat APL have adverse effects. 20(S)-ginsenoside Rh2 (GRh2) is an…
read more here.
Keywords:
degradation;
apoptosis;
grh2;
nb4 cells ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Pharmaceutical Biology"
DOI: 10.1080/13880209.2022.2118792
Abstract: Abstract Context Acute promyelocytic leukaemia (APL) is a malignant hematological tumour characterized by the presence of promyelocytic leukaemia–retinoic acid receptor A (PML-RARA) fusion protein. Cinobufagin (CBG) is one of the main effective components of toad…
read more here.
Keywords:
nb4 nb4;
pml;
pml rara;
catenin ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Acta Haematologica"
DOI: 10.1159/000498842
Abstract: The diagnostic hallmark of acute promyelocytic leukemia (APL) is the reciprocal translocation t(15;17), resulting in the characteristic PML-RARA fusion; however, patients occasionally have masked PML-RARArearrangements. We report an APL case with no evidence of t(15;17)…
read more here.
Keywords:
rara;
novel breakpoints;
within pml;
pml rara ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Blood"
DOI: 10.1182/blood.v130.suppl_1.2508.2508
Abstract: Inactivating mutations in Wilms Tumor 1 (WT1) are found in 5-10% of cases of acute myeloid leukemia (AML). Paradoxically, wild type WT1 is expressed highly in most cases of AML compared to normal hematopoietic progenitors,…
read more here.
Keywords:
pml rara;
leukemia;
wt1 expression;
wt1 ... See more keywords